(Q62105378)
Statements
A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured From the 2003 Measles Stock Seed With Recombinant Human Albumin (rHA) Versus Currently Licensed V205C Manufactured From the 1967 Measles Stock Seed With Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age (English)
0 references
October 2004
0 references
May 2005
0 references
1,100
0 references
12 month
0 references
18 month
0 references